Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 3673 - 3680 of 12093 results
Tip #2 for Avoiding IPR Institution: Focus on a few arguments that will affect all challenged claims
November 2, 2020| Blog| Viewpoint
Mintz Ramps Up West Coast Real Estate Practice With 3 New Members in LA
November 2, 2020| News
Counsel Must Educate Juries on US FRAND Rates
November 2, 2020| News
Lessons From Above: SCOTUS Declines to Review a Class Arbitrability Case (the Issue Had Been Delegated to an Arbitrator)
November 2, 2020| Blog| Viewpoint
The Patent Pool Explained: An Effective Mechanism When the Burden is Shared
October 30, 2020| News
US Health System Warned of Coordinated Ransomware Attacks
October 30, 2020| Blog| Viewpoint
Tip #1 for Avoiding IPR Institution: Litigation Venue Selection
October 29, 2020| Blog| Viewpoint
Women, Influence & Power in Law 2020: Terri Shieh-Newton
October 29, 2020| News
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|